EHR

HCA Healthcare Collaborates With Google Cloud to Bring Generative AI to Hospitals

AI technology to help improve workflows, reduce administrative burden and allow physicians and nurses to spend more time with patientsNASHVILLE,…

11 months ago

Get Well Achieves FedRAMP Authorized Designation

Company's Cross-Continuum Digital Patient Engagement Platform Will Enable Federal Organizations to Securely Personalize Patient Outreach Across a Full Episode of…

11 months ago

Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN I Trial of LYR-210 for the Treatment of Chronic Rhinosinusitis

Topline Results Expected 1H 2024WATERTOWN, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the…

11 months ago

T2 Biosystems Praises CDC’s Actions Aimed at Optimizing U.S. Hospital Sepsis Programs

The U.S. Centers for Disease Control and Prevention Releases 2023 Hospital Sepsis Program Core ElementsLEXINGTON, Mass., Aug. 28, 2023 (GLOBE…

11 months ago

Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024

WAKEFIELD, MA, Aug. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical…

11 months ago

Kymera Therapeutics to Participate in Upcoming September Investor Conferences

WATERTOWN, Mass., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein…

11 months ago

Genelux Corporation Announces New Chief Financial Officer

WESTLAKE VILLAGE, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced…

11 months ago

Fierce Biotech Names Proxygen a “Fierce 15” Biotech Company of 2023

VIENNA, Austria, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders,…

11 months ago

Mandatory notification of trade in Vistin Pharma ASA

Ferncliff Listed DAI AS has on 25 August 2023 purchased 200,000 shares in Vistin Pharma ASA at NOK 21 per…

11 months ago

Global Open Wound Care Selects eClinicalWorks EHR to Enhance Operations and Patient Care

Texas-based mobile wound care clinic to leverage eClinicalWorks Cloud and mobile platform for faster and more accurate decision-makingWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®,…

11 months ago